81176 Asxl1 gene target seq alys
Also known as: ASXL1 targeted testing, ASXL1 hotspot analysis
Targeted sequence analysis of the ASXL1 gene to identify specific mutations associated with myelodysplastic syndromes.
In Plain Language
bone marrow gene test; myelodysplasia mutation screening
Clinical Context
Employed to detect common ASXL1 mutations in myelodysplastic syndromes for prognostic assessment and treatment decision-making.
RVU Information
CPT 81176 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 81176?
CPT 81176 (Asxl1 gene target seq alys) is a Pathology & Lab code. Targeted sequence analysis of the ASXL1 gene to identify specific mutations associated with myelodysplastic syndromes.
Who uses CPT code 81176?
CPT 81176 is used by Hematology, Oncology, Pathology. Employed to detect common ASXL1 mutations in myelodysplastic syndromes for prognostic assessment and treatment decision-making.
When is CPT 81176 used?
Employed to detect common ASXL1 mutations in myelodysplastic syndromes for prognostic assessment and treatment decision-making.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.